Navigation Links
Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
Date:10/21/2013

WASHINGTON, Oct. 21, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the third quarter of 2013 on Thursday, November 7, 2013, before the market opens.

The Company will host a conference call at 10:00 AM ET on Thursday, November 7, 2013, during which Vanda management will discuss the financial results.  To participate in the conference call, please dial 1-888-895-5271 (domestic) or 1-847-619-6547 (international) and use passcode 35919679.

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com.  Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Thursday, November 7, 2013, beginning at 12:00 PM ET and will be accessible until Thursday, November 14, 2013, at 5:00 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 35919679.

ABOUT VANDA PHARMACEUTICALS INC.:    
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.  

Investor Contact:   
Chad Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@tro
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
2. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
3. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
4. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
5. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
6. Vanda Pharmaceuticals, Inc. Sued by Investor
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
9. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
10. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
11. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... China based on the number of directly ... General Meeting of Shareholders (the "AGM") on October 22, 2014 at ... meeting room of the Company at 6th Floor, Tower B, Xinnengyuan ... Guangdong Province 518054, People,s Republic of ...
(Date:9/19/2014)... , Sept. 19, 2014 Medical ... forging relationships with key opinion leaders (KOLs) who ... competition. Despite the critical nature of the MSL ... challenges, including altering the landscape for creating and ... According to research, the oversight responsibility for the ...
(Date:9/19/2014)... N.C. , Sept. 19, 2014 A ... Best Practices, LLC with three issues he wanted the ... The use of external personnel (especially for secondary research) ... in the face of increased workload , Automation ... better knowledge management , How to implement and ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2
... world-leading developer and marketer of innovative medical technologies for ... Bradford (Brad) Barton as President, ConvaTec U.S.   ... the ConvaTec U.S. organization across the company,s three core ... and Critical Care.   Barton joined ConvaTec ...
... SPRING, Md., Nov. 9, 2010 The U.S. Food ... undergoing computed tomography (CT) brain perfusion scans were accidently ... properly used, the CT scanners did not malfunction. Instead, ... scanners resulted in these overdoses. However, the FDA has ...
Cached Medicine Technology:Bradford Barton Named President, ConvaTec U.S. 2FDA Working to Prevent Radiation Overdoses During CT Scans 2FDA Working to Prevent Radiation Overdoses During CT Scans 3
(Date:9/22/2014)... ARBOR, Mich. A surprising new study pulls back ... in health care: differences in payment and income between ... who don,t. , Contrary to perception, the research ... to favor surgeons and other procedure-performing doctors. , The ... simple difference in pay per minute explains why doctors ...
(Date:9/22/2014)... Amy Norton HealthDay Reporter ... may fare better when newborn intensive care units (NICU) set ... infants, a new study finds. Researchers at one children,s ... and were less distressed when their NICU switched from the ... findings, published online Sept. 22 in the journal Pediatrics ...
(Date:9/22/2014)... patients undergoing breast cancer surgery require additional operations because ... in the initial operation. However, researchers at Brigham and ... developed that will help surgeons better distinguish cancerous breast ... repeat operations. , The study is ... the Proceedings of the National Academy of Sciences ...
(Date:9/22/2014)... scientists have found that an anticonvulsant drug may help ... Although dozens of antibiotics target what bacteria do, their ... bacteria are created, and they found there is a ... important as there is growing concern worldwide about how ... The World Health Organization has declared that antibiotic resistance ...
(Date:9/22/2014)... September 22, 2014 This Flash Report ... stakeholder management needs for the Prostate Cancer market. , ... on stakeholder strategies for any launching Prostate Cancer product:, ... differentiation within an increasingly crowded market , ... impact of identifying community-based thought leaders and stakeholders ...
Breaking Medicine News(10 mins):Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:The fine line between breast cancer and normal tissues 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2
... protein previously thought not to exist in adult human lungs ... scientists have found, but it also has a major role ... cancers. The protein, called the calcium-sensing receptor, sits on ... known as squamous-cell carcinomas, according to new research. As ...
... new source of stem cells A team ... Institute for Biological Studies, La Jolla, has generated data in ... tissue in the smell-sensing region of the human nose (human ... cells to treat brain disorders in which nerve cells are ...
... couples is affected by wives, inability to fall asleep at ... that will be presented Monday, June 13, in Minneapolis, Minn., ... Professional Sleep Societies LLC (APSS). Results show ... predicted their reports of more negative and less positive marital ...
... studied controversial aspects of Medicare spending and quality ... from the nation,s largest health services research professional ... 2011 Article of the Year Award to Jeffrey ... for Outcomes Research at The Children,s Hospital of ...
... MONDAY, June 13 (HealthDay News) -- Breast-feeding appears to reduce ... especially when babies are exclusively breast-fed, a new study suggests. ... infants, and studies have shown breast-feeding aids babies, development and ... mothers. Now, there is more evidence that breast-feeding may reduce ...
... about the signs and symptoms of drug impairment among ... Houston State University (SHSU) June 14. The free, six-hour ... Sept. 1, 2011., The program, funded by the Texas ... including human resources personnel, owners and executive staff. The ...
Cached Medicine News:Health News:Scientists identify key component in lethal lung cancer complication 2Health News:Scientists identify key component in lethal lung cancer complication 3Health News:Scientists identify key component in lethal lung cancer complication 4Health News:JCI online early table of contents: June 13, 2011 2Health News:JCI online early table of contents: June 13, 2011 3Health News:JCI online early table of contents: June 13, 2011 4Health News:JCI online early table of contents: June 13, 2011 5Health News:JCI online early table of contents: June 13, 2011 6Health News:JCI online early table of contents: June 13, 2011 7Health News:JCI online early table of contents: June 13, 2011 8Health News:JCI online early table of contents: June 13, 2011 9Health News:JCI online early table of contents: June 13, 2011 10Health News:Study finds that wives' sleep problems have negative impact on marital interactions 2Health News:Hospital outcomes research named 'Article of the Year' 2Health News:Hospital outcomes research named 'Article of the Year' 3Health News:Breast-feeding May Shield Against Sudden Infant Death Syndrome 2Health News:Breast-feeding May Shield Against Sudden Infant Death Syndrome 3Health News:Drug recognition program available for Texas employers 2
Fixed smooth rod which slides on skin. Designated most popular model or size....
Grooved roller, on which knife oscillates....
Disposable. For use with the N4086....
30 mm button end blade. Flat handle....
Medicine Products: